▶ 調査レポート

非侵襲的結腸がんスクリーニングの世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Non Invasive Colon Cancer Screening Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。非侵襲的結腸がんスクリーニングの世界市場 2020年:企業別、地域別、種類・用途別 / Global Non Invasive Colon Cancer Screening Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-16175資料のイメージです。• レポートコード:D0804-16175
• 出版社/出版日:GlobalInfoResearch / 2020年7月28日
※2025年版があります。お問い合わせください。

• レポート形態:英語、PDF、100ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、非侵襲的結腸がんスクリーニングの世界市場を広く調査・分析し、今後の市場展望をまとめております。非侵襲的結腸がんスクリーニングの種類別市場規模(糞便免疫化学検査(FIT)、グアイアック便潜血検査(gFOBT))、用途別市場規模(病院、専門クリニック、外来手術センター、診断センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Abbott Laboratories、CML Healthcare, Inc.、Sysmex Corporation、Beckman Coulter, Inc.、Novigenix SA、Epigenomics AG、Exact Sciences Corporation、Quest Diagnostics
・地域別グローバル市場分析 2015年-2020年
・非侵襲的結腸がんスクリーニングの北米市場(アメリカ、カナダ、メキシコ)
・非侵襲的結腸がんスクリーニングのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・非侵襲的結腸がんスクリーニングのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・非侵襲的結腸がんスクリーニングの南米市場(ブラジル、アルゼンチン)
・非侵襲的結腸がんスクリーニングの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:糞便免疫化学検査(FIT)、グアイアック便潜血検査(gFOBT)
・用途別分析:病院、専門クリニック、外来手術センター、診断センター、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Non Invasive Colon Cancer Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Non Invasive Colon Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Non Invasive Colon Cancer Screening market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Non Invasive Colon Cancer Screening market has been segmented into:
Fecal Immunochemical Test (FIT)
Guaiac-based Fecal Occult Blood Test (gFOBT)

By Application, Non Invasive Colon Cancer Screening has been segmented into:
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non Invasive Colon Cancer Screening market presented in the report. This section sheds light on the sales growth of different regional and country-level Non Invasive Colon Cancer Screening markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non Invasive Colon Cancer Screening market.

The report offers in-depth assessment of the growth and other aspects of the Non Invasive Colon Cancer Screening market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Non Invasive Colon Cancer Screening Market Share Analysis
Non Invasive Colon Cancer Screening competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non Invasive Colon Cancer Screening sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non Invasive Colon Cancer Screening sales, revenue and market share for each player covered in this report.

The major players covered in Non Invasive Colon Cancer Screening are:
Abbott Laboratories
CML Healthcare, Inc.
Sysmex Corporation
Beckman Coulter, Inc.
Novigenix SA
Epigenomics AG
Exact Sciences Corporation
Quest Diagnostics

レポート目次

Table of Contents

1 Non Invasive Colon Cancer Screening Market Overview
1.1 Product Overview and Scope of Non Invasive Colon Cancer Screening
1.2 Classification of Non Invasive Colon Cancer Screening by Type
1.2.1 Global Non Invasive Colon Cancer Screening Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Non Invasive Colon Cancer Screening Revenue Market Share by Type in 2019
1.2.3 Fecal Immunochemical Test (FIT)
1.2.4 Guaiac-based Fecal Occult Blood Test (gFOBT)
1.3 Global Non Invasive Colon Cancer Screening Market by Application
1.3.1 Overview: Global Non Invasive Colon Cancer Screening Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Global Non Invasive Colon Cancer Screening Market by Regions
1.4.1 Global Non Invasive Colon Cancer Screening Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Non Invasive Colon Cancer Screening (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Non Invasive Colon Cancer Screening Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Non Invasive Colon Cancer Screening Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non Invasive Colon Cancer Screening Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Non Invasive Colon Cancer Screening Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non Invasive Colon Cancer Screening Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.2 CML Healthcare, Inc.
2.2.1 CML Healthcare, Inc. Details
2.2.2 CML Healthcare, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CML Healthcare, Inc. SWOT Analysis
2.2.4 CML Healthcare, Inc. Product and Services
2.2.5 CML Healthcare, Inc. Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sysmex Corporation
2.3.1 Sysmex Corporation Details
2.3.2 Sysmex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sysmex Corporation SWOT Analysis
2.3.4 Sysmex Corporation Product and Services
2.3.5 Sysmex Corporation Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beckman Coulter, Inc.
2.4.1 Beckman Coulter, Inc. Details
2.4.2 Beckman Coulter, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beckman Coulter, Inc. SWOT Analysis
2.4.4 Beckman Coulter, Inc. Product and Services
2.4.5 Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novigenix SA
2.5.1 Novigenix SA Details
2.5.2 Novigenix SA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novigenix SA SWOT Analysis
2.5.4 Novigenix SA Product and Services
2.5.5 Novigenix SA Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.6 Epigenomics AG
2.6.1 Epigenomics AG Details
2.6.2 Epigenomics AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Epigenomics AG SWOT Analysis
2.6.4 Epigenomics AG Product and Services
2.6.5 Epigenomics AG Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.7 Exact Sciences Corporation
2.7.1 Exact Sciences Corporation Details
2.7.2 Exact Sciences Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Exact Sciences Corporation SWOT Analysis
2.7.4 Exact Sciences Corporation Product and Services
2.7.5 Exact Sciences Corporation Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.8 Quest Diagnostics
2.8.1 Quest Diagnostics Details
2.8.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Quest Diagnostics SWOT Analysis
2.8.4 Quest Diagnostics Product and Services
2.8.5 Quest Diagnostics Non Invasive Colon Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Non Invasive Colon Cancer Screening Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Non Invasive Colon Cancer Screening Players Market Share
3.2.2 Top 10 Non Invasive Colon Cancer Screening Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Non Invasive Colon Cancer Screening Revenue and Market Share by Regions
4.2 North America Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
4.3 Europe Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
4.5 South America Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
5 North America Non Invasive Colon Cancer Screening Revenue by Countries
5.1 North America Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
5.2 USA Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
5.3 Canada Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
5.4 Mexico Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
6 Europe Non Invasive Colon Cancer Screening Revenue by Countries
6.1 Europe Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
6.2 Germany Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
6.3 UK Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
6.4 France Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
6.5 Russia Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
6.6 Italy Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Non Invasive Colon Cancer Screening Revenue by Countries
7.1 Asia-Pacific Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
7.2 China Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
7.3 Japan Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
7.4 Korea Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
7.5 India Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
8 South America Non Invasive Colon Cancer Screening Revenue by Countries
8.1 South America Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
8.2 Brazil Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
8.3 Argentina Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Non Invasive Colon Cancer Screening by Countries
9.1 Middle East & Africa Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
9.2 Saudi Arabia Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
9.3 UAE Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
9.4 Egypt Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
9.5 South Africa Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Non Invasive Colon Cancer Screening Revenue and Market Share by Type (2015-2020)
10.2 Global Non Invasive Colon Cancer Screening Market Forecast by Type (2019-2024)
10.3 Fecal Immunochemical Test (FIT) Revenue Growth Rate (2015-2025)
10.4 Guaiac-based Fecal Occult Blood Test (gFOBT) Revenue Growth Rate (2015-2025)
11 Global Non Invasive Colon Cancer Screening Market Segment by Application
11.1 Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2015-2020)
11.2 Non Invasive Colon Cancer Screening Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Speciality Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Diagnostic Centers Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Non Invasive Colon Cancer Screening Market Size Forecast (2021-2025)
12.1 Global Non Invasive Colon Cancer Screening Market Size Forecast (2021-2025)
12.2 Global Non Invasive Colon Cancer Screening Market Forecast by Regions (2021-2025)
12.3 North America Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
12.4 Europe Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
12.6 South America Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Non Invasive Colon Cancer Screening Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non Invasive Colon Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non Invasive Colon Cancer Screening Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Non Invasive Colon Cancer Screening Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Non Invasive Colon Cancer Screening Major Business
Table 7. Abbott Laboratories Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Non Invasive Colon Cancer Screening Product and Solutions
Table 10. Abbott Laboratories Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. CML Healthcare, Inc. Corporate Information, Location and Competitors
Table 12. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Major Business
Table 13. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2018-2019)
Table 14. CML Healthcare, Inc. SWOT Analysis
Table 15. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Product and Solutions
Table 16. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sysmex Corporation Corporate Information, Location and Competitors
Table 18. Sysmex Corporation Non Invasive Colon Cancer Screening Major Business
Table 19. Sysmex Corporation Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 20. Sysmex Corporation SWOT Analysis
Table 21. Sysmex Corporation Non Invasive Colon Cancer Screening Product and Solutions
Table 22. Sysmex Corporation Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beckman Coulter, Inc. Corporate Information, Location and Competitors
Table 24. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Major Business
Table 25. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 26. Beckman Coulter, Inc. SWOT Analysis
Table 27. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Product and Solutions
Table 28. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novigenix SA Corporate Information, Location and Competitors
Table 30. Novigenix SA Non Invasive Colon Cancer Screening Major Business
Table 31. Novigenix SA Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 32. Novigenix SA SWOT Analysis
Table 33. Novigenix SA Non Invasive Colon Cancer Screening Product and Solutions
Table 34. Novigenix SA Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Epigenomics AG Corporate Information, Location and Competitors
Table 36. Epigenomics AG Non Invasive Colon Cancer Screening Major Business
Table 37. Epigenomics AG Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 38. Epigenomics AG SWOT Analysis
Table 39. Epigenomics AG Non Invasive Colon Cancer Screening Product and Solutions
Table 40. Epigenomics AG Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Exact Sciences Corporation Corporate Information, Location and Competitors
Table 42. Exact Sciences Corporation Non Invasive Colon Cancer Screening Major Business
Table 43. Exact Sciences Corporation Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 44. Exact Sciences Corporation SWOT Analysis
Table 45. Exact Sciences Corporation Non Invasive Colon Cancer Screening Product and Solutions
Table 46. Exact Sciences Corporation Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Quest Diagnostics Corporate Information, Location and Competitors
Table 48. Quest Diagnostics Non Invasive Colon Cancer Screening Major Business
Table 49. Quest Diagnostics Non Invasive Colon Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 50. Quest Diagnostics SWOT Analysis
Table 51. Quest Diagnostics Non Invasive Colon Cancer Screening Product and Solutions
Table 52. Quest Diagnostics Non Invasive Colon Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Non Invasive Colon Cancer Screening Revenue (Million USD) by Players (2015-2020)
Table 54. Global Non Invasive Colon Cancer Screening Revenue Share by Players (2015-2020)
Table 55. Global Non Invasive Colon Cancer Screening Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Non Invasive Colon Cancer Screening Revenue Market Share by Regions (2015-2020)
Table 57. North America Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
Table 58. North America Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Table 59. Europe Non Invasive Colon Cancer Screening Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Non Invasive Colon Cancer Screening Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Non Invasive Colon Cancer Screening Revenue by Countries (2015-2020)
Table 62. South America Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Non Invasive Colon Cancer Screening Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Table 65. Global Non Invasive Colon Cancer Screening Revenue (Million USD) by Type (2015-2020)
Table 66. Global Non Invasive Colon Cancer Screening Revenue Share by Type (2015-2020)
Table 67. Global Non Invasive Colon Cancer Screening Revenue Forecast by Type (2021-2025)
Table 68. Global Non Invasive Colon Cancer Screening Revenue by Application (2015-2020)
Table 69. Global Non Invasive Colon Cancer Screening Revenue Share by Application (2015-2020)
Table 70. Global Non Invasive Colon Cancer Screening Revenue Forecast by Application (2021-2025)
Table 71. Global Non Invasive Colon Cancer Screening Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Non Invasive Colon Cancer Screening Picture
Figure 2. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type in 2019
Figure 3. Fecal Immunochemical Test (FIT) Picture
Figure 4. Guaiac-based Fecal Occult Blood Test (gFOBT) Picture
Figure 5. Non Invasive Colon Cancer Screening Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Speciality Clinics Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Others Picture
Figure 11. Global Non Invasive Colon Cancer Screening Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Non Invasive Colon Cancer Screening Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Non Invasive Colon Cancer Screening Revenue Market Share in 2019
Figure 20. Global Top 10 Players Non Invasive Colon Cancer Screening Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Non Invasive Colon Cancer Screening Revenue Market Share by Regions (2015-2020)
Figure 24. Global Non Invasive Colon Cancer Screening Revenue Market Share by Regions in 2018
Figure 25. North America Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 26. Europe Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 28. South America Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 30. North America Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 31. North America Non Invasive Colon Cancer Screening Revenue Market Share by Countries in 2019
Figure 32. USA Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 33. Canada Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 35. Europe Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Non Invasive Colon Cancer Screening Revenue Market Share by Countries in 2019
Figure 37. Germany Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 38. UK Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 39. France Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 40. Russia Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 41. Italy Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Non Invasive Colon Cancer Screening Revenue Market Share by Countries in 2019
Figure 44. China Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 45. Japan Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 46. Korea Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 47. India Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 49. South America Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 50. South America Non Invasive Colon Cancer Screening Revenue Market Share by Countries in 2019
Figure 51. Brazil Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Non Invasive Colon Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Non Invasive Colon Cancer Screening Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 56. UAE Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Non Invasive Colon Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 59. Global Non Invasive Colon Cancer Screening Revenue Share by Type (2015-2020)
Figure 60. Global Non Invasive Colon Cancer Screening Revenue Share by Type in 2019
Figure 61. Global Non Invasive Colon Cancer Screening Market Share Forecast by Type (2021-2025)
Figure 62. Global Fecal Immunochemical Test (FIT) Revenue Growth Rate (2015-2020)
Figure 63. Global Guaiac-based Fecal Occult Blood Test (gFOBT) Revenue Growth Rate (2015-2020)
Figure 64. Global Non Invasive Colon Cancer Screening Revenue Share by Application (2015-2020)
Figure 65. Global Non Invasive Colon Cancer Screening Revenue Share by Application in 2019
Figure 66. Global Non Invasive Colon Cancer Screening Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Speciality Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Non Invasive Colon Cancer Screening Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Non Invasive Colon Cancer Screening Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Non Invasive Colon Cancer Screening Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
Figure 76. Europe Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
Figure 78. South America Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Non Invasive Colon Cancer Screening Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel